FDA Approves Zilbrysq for Myasthenia Gravis
Zilbrysq (zilucoplan) is the first self-administered treatment for myasthenia gravis. Rapid symptom improvements were observed in clinical trials.
United States University Of North Carolina North Carolina Palo Alto Winston Salem Rachana Gandhi Mehta
Source: everydayhealth.com